Clinical Trial Update: An Epidemiology Study of Treatment Resistant Depression in the United States (US)

View source ↗

Summary

This is a completed epidemiology study in the United States examining treatment-resistant depression, sponsored by Janssen Research & Development, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Treatment-resistant Depression

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Treatment-Resistant | Status: COMPLETED